---
$id: https://graph.org.ai/products/commodity/51131657
$type: Product
source: UNSPSC
code: "51131657"
title: "Ximelagatran"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ximelagatran

**UNSPSC Code**: 51131657
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticoagulant agent with the molecular formula C24H35N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49HFB70472, chemically known as glycine, n-((1r)-1-cyclohexyl-2-((2s)-2-((((4-((hydroxyamino)iminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-2-oxoethyl)-, ester ester but generally known as ximelagatran, which bears US NIH Compound Identifier 9574101. European Medicines Agency schedules Ximelagatran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB16473MIG. The term XIMELAGATRAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 3-4, 2001, List 46). World Health Organization schedules ximelagatran in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule ximelagatran under HS 29339990 and SITC 51577. As of Q4 2014, XIMELAGATRAN remains the US FDA Preferred Term for this commodity. Ximelagatran bears US NLM identifiers UMLS ID C0966370 and NCI Concept Code C77996. SMILES: O=C(N1C(CC1)C(=O)NCC1CCC(CC1)C(=N\O)\N)C(NCC(=O)OCC)C1CCCCC1.

